Cellecta, Inc

Cellecta provides HT loss-of-function genetic screening services for the discovery and functional characterization of novel therapeutic targets. We offer pooled lentiviral shRNA and CRISPR libraries, pooled library screening and analysis by NGS, targeted RNA-Seq for biomarker discovery, lentiviral reagents, and stable cDNA, shRNA, and CRISPR constructs and isogenic cell lines

Pooled lentiviral crispr and shrna libraries,loss-of-function genetic screens with pooled libraries,custom isogenic cell lines,custom crispr,shrna,and cdna constructs,cell-tracking lentiviral barcode libraries,and targeted gene expression profiling

Cellecta, inc operates in the Biotechnology research industry.

Cellecta, inc's revenue is 1m - 10m

Cellecta, inc has 11 - 50 employees.